Muscle expression of IGF-I was decreased in CKD mice, and GH treatments normalized muscle IGF-I expression as well as restored the phosphorylated JAK2 and STAT5 muscle protein levels to normal in CKD mice (Figure 5K–M). This evidence concerns the gene GH1 and chronic kidney disease.